secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2023-05-19T23:59:59+00:00
Accession:  0001193125-23-149463
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DexCom amends severance plan boosting CEO payouts; shareholders reelect directors and set say-on-pay to annual
--------------------------------------------------------------------------------

- CEO severance salary increased to 24 months (from 18) outside change of control; to 36 months (from 18) during a change of control.
- C-Level/SVP executives' severance salary during change of control increased to 24 months (from 12).
- Shareholders elected all seven director nominees, each receiving between ~324M and ~333M votes for.
- Non-binding say-on-pay approved with ~93% support; shareholders voted for annual frequency.
- Stockholder proposal on pay equity disclosure rejected with ~64% against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000119312523149463/0001193125-23-149463-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000119312523149463/d446905d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-149463

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer